INDEPENDENT INTELLIGENCE
LATESTSEARCH ⌕
NASDAQ / LIVE COMPANY INTELLIGENCE

Artiva Biotherapeutics, Inc.

Nasdaq-listed company. Follow earnings, filings, products, capital and the competitive forces moving the company.

TICKERARTV
CORENasdaq-listed company
WATCHEarnings + filings + operating news
STATUSContinuously updated
LIVE / ARTV COVERAGE

What’s moving Artiva Biotherapeutics, Inc. now

Current reporting with the operating signal separated from the noise.

01
Is Artiva Biotherapeutics, Inc. (ARTV) Outperforming Other Medical Stocks This Year?

Is Artiva Biotherapeutics, Inc. (ARTV) Outperforming Other Medical Stocks This Year?

Investors are testing whether Artiva Biotherapeutics, Inc.’s operating performance supports its strategy and valuation.

Watch next: the filing, cash flow, guidance and capital-expenditure plan.
PRIMARY DOCUMENTS / SEC EDGAR

Latest ARTV filings.

Investor-relevant reports are shown first, followed by the company’s other recent official submissions.

10-QQuarterly financial reportFiled 2026-05-08 · Period 2026-03-31SEC ↗10-QQuarterly financial reportFiled 2025-11-12 · Period 2025-09-30SEC ↗10-K/AAnnual financial reportFiled 2026-04-30 · Period 2025-12-31SEC ↗8-KMaterial company eventFiled 2026-07-22 · Period 2026-07-22SEC ↗8-KMaterial company eventFiled 2026-05-19 · Period 2026-05-18SEC ↗8-KMaterial company eventFiled 2026-05-08 · Period 2026-05-08SEC ↗DEF 14AProxy and shareholder meetingFiled 2026-08-03 · Period 2026-09-08SEC ↗ARSOfficial SEC filingFiled 2026-08-03 · Period 2025-12-31SEC ↗
EARNINGS / QUARTERLY TRACKER

Artiva Biotherapeutics, Inc., quarter by quarter.

Results, guidance and earnings coverage are grouped only when the source headline identifies the reporting period.